Acute Heart Failure Syndromes in Patients With Coronary Artery Disease. Early Assessment and Treatment

Journal of the American College of Cardiology

Volumn 53, Issue 3, 2009, Pages 254-263

  Flaherty, James D ^a   Bax, Jeroen J ^b   De Luca, Leonardo ^c   Rossi, Joseph S ^a   Davidson, Charles J ^a   Filippatos, Gerasimos ^d   Liu, Peter P ^e   Konstam, Marvin A ^f   Greenberg, Barry ^g   Mehra, Mandeep R ^h   Breithardt, Günter ⁱ   Pang, Peter S ^a   Young, James B ^j   Fonarow, Gregg C ^k   Bonow, Robert O ^a   Gheorghiade, Mihai ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c EUROPEAN HOSPITAL   (Italy)

^d NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^e TORONTO GENERAL HOSPITAL   (Canada)

^f TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^j LERNER RESEARCH INSTITUTE   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

acute heart failure; assessment; coronary artery disease

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; EPLERENONE; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MILRINONE; NESIRITIDE; NITRATE; PLACEBO; VASOACTIVE AGENT;

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; CARDIAC PATIENT; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DRUG MEGADOSE; EARLY DIAGNOSIS; EARLY INTERVENTION; HEALTH CARE COST; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE FUNCTION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LOW DRUG DOSE; MORTALITY; MYOCARDIAL HIBERNATION; NONHUMAN; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY ARTERY CATHETER; REVIEW; STUNNED HEART MUSCLE;

ACUTE DISEASE; COMBINED MODALITY THERAPY; COMORBIDITY; CORONARY DISEASE; FEMALE; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MALE; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS; SYNDROME;

EID: 58149302434     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.08.072     Document Type: Review

References (111)

1. Gheorghiade M., Zannad F., Sopko G., et al. Acute heart failure syndromes: current state and framework for future research. Circulation 112 (2005) 3958-3968
2. Solomon S.D., Dobson J., Pocock S., et al. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation 116 (2007) 1482-1487
3. Ahmed A., Allman R.M., Fonarow G.C., et al. Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study. J Cardiac Fail 14 (2008) 211-218
4. Jong P., Vowinckel E., Liu P.P., et al. Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. Arch Intern Med 162 (2002) 1689-1694
5. Goldberg R.J., Ciampa J., Lessard D., et al. Long-term survival after heart failure: a contemporary population-based perspective. Arch Intern Med 167 (2007) 490-496
6. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 46 (2005) e1-e82
7. Guidelines on the diagnosis and treatment of acute heart failure. Available at: http://www.escardio.org/. Accessed May 1, 2008.
8. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. J Am Coll Cardiol 50 (2007) e1-e157
9. Eagle K.A., Guyton R.A., Davidoff R., et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery. Summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 44 (2004) e213-e310
10. Smith Jr. S.C., Feldman T.E., Hirshfeld J.W., et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 47 (2005) 216-235
11. Silber S., Albertsson P., Aviles F.F., et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26 (2005) 804-807
12. Rosamond W., Flegal K., Friday G., et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115 (2007) e69-e171
13. DeFrances C.J., and Podgornik M.N. 2004 National Hospital Discharge Survey (2006), CDC, Atlanta, GA
14. Thom T., Haase N., Rosamond W., et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113 (2006) e85-e151
15. Bardy G.H., Lee K.L., Mark D.B., et al. for the SCD-HeFT Investigators. Amiodarone or an implantable cardiac-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
16. McAlister F.A., Ezekowitz J., Hooton N., et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction. JAMA 297 (2007) 2502-2514
17. Fonarow G.C., Abraham W.T., Albert N.M., et al. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA 297 (2007) 61-70
18. Adams J.K.F., Fonarow G.C., Emerman C.L., et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149 (2005) 209-216
19. Cleland J.G.F., Swedberg K., Follath F., et al. The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe: Part 1: patient characteristics and diagnosis. Eur Heart J 24 (2003) 442-463
20. The ESCAPE Investigators. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 294 (2005) 1625-1633
21. Gheorghiade M., Gattis W.A., O'Connor C.M., et al. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA 291 (2004) 1963-1971
22. Cuffe M.S., Califf R.M., Adams Jr. K.F., et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 287 (2002) 1541-1547
23. Sackner-Bernstein J., Kowalski M., Fox M., et al. Short-term risk of death after treatment with nesiritide for decompensated heart failure. JAMA 293 (2005) 1900-1905
24. Konstam M.A., Gheorghiade M., Burnett Jr. J.C., et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial. JAMA 297 (2007) 1319-1331
25. Mebazaa A., Nieminen M.S., Packer M., et al. Levosimendan vs. dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial. JAMA 297 (2007) 1883-1891
26. Felker G.M., Benza R.L., Chandler A.B., et al. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. J Am Coll Cardiol 41 (2003) 997-1003
27. Schultz R., Rose J., Martin C., Brodde O.E., and Heusch G. Development of short-term myocardial hibernation. Circulation 88 (1993) 684-695
28. Beohar N., Erdogan A.K., Lee D.C., et al. Acute heart failure syndromes and coronary perfusion. J Am Coll Cardiol 52 (2008) 13-16
29. Owan T.E., Hodge D.O., Herges R.M., et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355 (2006) 251-259
30. Fonarow G.C., Gattis Stough W., Abraham W.T., et al. Characteristics, treatments and outcomes of patients with preserved systolic function hospitalized with heart failure: a report from OPTIMIZE-HF. J Am Coll Cardiol 50 (2007) 768-777
31. Judge K.W., Pawitan Y., Caldwell J., et al. Congestive heart failure symptoms in patients with preserved left ventricular systolic function: analysis of the CASS registry. J Am Coll Cardiol 18 (1991) 377-382
32. Bhatia R.S., Tu J.V., Lee D.S., et al. Outcome of heart failure with preserved ejection fraction in a population based study. N Engl J Med 355 (2007) 260-269
33. Lenzen M.J., Scholte op Reimer W.J.M., Boersma E., et al. Differences between patients with preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J 25 (2004) 1214-1220
34. Tribouilloy C., Rusinaru D., Mahjoub H., et al. Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study. Eur Heart J 29 (2008) 339-347
35. Siirilä-Waris K., Lassus J., Melin J., et al. Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure. Eur Heart J 27 (2006) 3011-3017
36. Gheorghiade M., Sopko G., De Luca L., et al. Navigating the crossroads of coronary artery disease and heart failure. Circulation 114 (2006) 1202-1213
37. Shah S.J., and Gheorghiade M. Heart failure with preserved ejection fraction. JAMA 300 (2008) 431-433
38. Ahmed A., Rich M.W., Fleg J.L., et al. Effects of digoxin on morbidity and mortality in diastolic heart failure. Circulation 114 (2006) 397-403
39. Purek L., Laule-Kilian K., Christ A., et al. Coronary artery disease and outcome in acute congestive heart failure. Heart 92 (2006) 598-602
40. Felker G.M., Shaw L.K., and O'Connor C.M. A standardized definition of ischemic cardiomyopathy for use in clinical research. Circulation 39 (2002) 210-218
41. Bart B.A., Shaw L.K., McCants Jr. B.S.C.B., et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 30 (1997) 1002-1008
42. Torabi A., Cleland J.G.F., Khan N.K., et al. The timing of development and subsequent clinical course of heart failure after a myocardial infarction. Eur Heart J 29 (2008) 859-870
43. Fox K.F., Cowie M.R., Wood D.A., et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J 22 (2001) 228-236
44. Fonarow G.C., Abraham W.T., Albert N.M., et al. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Arch Intern Med 168 (2008) 847-854
45. Orn S., Cleland J.G.F., Romo M., et al. Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction. Am J Med 118 (2005) 752-758
46. Uretsky B.F., Thygesen K., Armstrong P.W., et al. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the Assessment of Treatment with Lisinopril and Survival (ATLAS) trial. Circulation 102 (2000) 611-616
47. Cleland J.G.F., Thygesen K., Uretsky B.F., et al. Cardiovascular critical event pathways for the progression of heart failure: a report from the ATLAS study. Eur Heart J 22 (2001) 1601-1612
48. Hedrich O., Jacob M., and Hauptman P. Progression of coronary artery disease in non-ischemic dilated cardiomyopathy. Cor Art Dis 15 (2004) 291-297
49. Gheorghiade M., Abraham W.T., Albert N.M., et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 296 (2006) 2217-2226
50. Horwich T.B., Patel J., MacLellan W.R., et al. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 108 (2003) 833-838
51. You J.J., Austin P.C., Alter D.A., et al. Relation between cardiac troponin I and mortality in acute decompensated heart failure. Am Heart J 153 (2007) 462-470
52. Metra M., Nodari S., Parrinello G., et al. The role of plasma biomarkers in acute heart failure: serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T. Eur J Heart Fail 9 (2007) 776-786
53. Tavazzi L., Maggioni A.P., Lucci D., et al. Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J 27 (2006) 1207-1215
54. Gheorghiade M., Gattis Stough W., Adams Jr. K.F., et al. The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF). Am J Cardiol 96 (2005) 18G-25
55. Peacock W.F., De Marco T., Fonarow G.C., et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med 358 (2008) 2117-2126
56. Rossi J.S., Flaherty J.D., Fonorow G.C., et al. Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: a report from OPTIMIZE-HF. Eur J Heart Fail 10 (2008) 1215-1223
57. Lettman N.A., Sites F.D., Shofer F.S., and Hollander J.E. Congestive heart failure patients with chest pain: incidence and predictors of acute coronary syndrome. Acad Emerg Med 9 (2002) 903-909
58. Roe M.T., Chen A.Y., Riba A.L., et al. Impact of congestive heart failure in patients with non-ST-segment elevation acute coronary syndromes. Am J Cardiol 97 (2006) 1707-1712
59. Khot U.N., Jia G., Moliterno D.J., et al. Prognostic Importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification. JAMA 290 (2003) 2174-2181
60. Steg P.G., Dabbous O.H., Feldman L.J., et al. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Circulation 109 (2004) 494-499
61. Di Chiara A., Fresco C., Savonitto S., et al. Epidemiology of non-ST elevation acute coronary syndromes in the Italian cardiology network: the BLITZ-2 study. Eur Heart J 27 (2006) 393-405
62. Shibata M.C., Collinson J., Taneja A.K., et al. Long term prognosis of heart failure after acute coronary syndromes without ST elevation. Postgrad Med J 82 (2006) 55-59
63. Spencer F.A., Meyer T.E., Gore J.M., et al. Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure: the national registry of myocardial infarction. Circulation 105 (2002) 2605-2610
64. Nieminen M.S., Brutsaert K., Dickstein K., et al. Euroheart failure survey II: a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27 (2006) 2725-2736
65. Gattis W.A., O'Connor C.M., Hasselblad V., Adams K.F., Kobrin I., and Gheorghiade M. Usefulness of an elevated troponin-I in predicting clinical events in patients for acute heart failure and acute coronary syndrome (from the RITZ-4 trial). Am J Cardiol 93 (2004) 1436-1437
66. Emanuelsson H., Karlson B.W., and Herlitz J. Characteristics and prognosis of patients with acute myocardial infarction in relation to occurrence of congestive heart failure. Eur Heart J 15 (1994) 761-768
67. O'Connor C.M., Hathaway W.R., Bates E.R., et al. Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model. Am Heart J 133 (1997) 663-673
68. Hasdai D., Topol E.J., Kilaru R., et al. Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials. Am Heart J 145 (2003) 73-79
69. Ali A.S., Rybicki B.A., Alam M., et al. Clinical predictors of heart failure in patients with first acute myocardial infarction. Am Heart J 138 (1999) 1133-1139
70. Spencer F.A., Meyer T.E., Goldberg R.J., et al. Twenty-year trends (1975-1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol 34 (1999) 1378-1387
71. Wu A.H., Parsons L., Every N.R., Bates E.R., and Second National Registry of Myocardial Infarction. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 40 (2002) 1389-1394
72. Segev A., Strauss B.H., Tan M., et al., Canadian Acute Coronary Syndrome Registries Investigators. Prognostic significance of admission heart failure in patients with non-ST-elevation acute coronary syndromes. Am J Cardiol 98 (2006) 470-473
73. Haim M., Battler A., Behar S., et al. Acute coronary syndromes complicated by symptomatic and asymptomatic heart failure: does current treatment comply with guidelines?. Am Heart J 147 (2004) 859-864
74. Whellan D.J., Tuttle R.H., Velazquez E.J., et al. Predicting significant coronary artery disease in patients with left ventricular dysfunction. Am Heart J 152 (2006) 340-347
75. Sawada S.G., Ryan T., Segar D., et al. Distinguishing ischemic cardiomyopathy from nonischemic dilated cardiomyopathy with coronary echocardiography. J Am Coll Cardiol 19 (1992) 1223-1228
76. O'Connor C.M., Gattis W.A., Shaw L., Cuffe M.S., and Califf R.M. Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function. Am J Cardiol 86 (2000) 863-867
77. Kurtz C.E., Gerber Y., Weston S.A., et al. Use of ejection fraction tests and coronary angiography in patients with heart failure. Mayo Clinic Proc 81 (2006) 906-913
78. Srichai M.B., Jaber W.A., Prior D.L., et al. Evaluating the benefits of glycoprotein IIb/IIIa inhibitors in heart failure at baseline in acute coronary syndromes. Am Heart J 147 (2004) 84-90
79. Lewis E.F., Velazquez E.J., Solomon S.D., et al. Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study. Eur Heart J 29 (2008) 748-756
80. Flaherty J.D., Rossi J.S., Davidson C.J., et al. Influence of coronary angiography on therapy utilization and survival in acute heart failure: a report from the OPTIMIZE-HF registry. (abstr). Am J Cardiol 102 Suppl 1 (2008) 25I
81. Andreini D., Pontone G., Pepi M., et al. Diagnostic accuracy of multidetector computed tomography coronary angiography in patients with dilated cardiomyopathy. J Am Coll Cardiol 49 (2007) 2044-2050
82. Shapiro M.D., Butler J., Rieber J., et al. Analytic approaches to establish the diagnostic accuracy of coronary computed tomography angiography as a tool for clinical decision making. Am J Cardiol 99 (2007) 1122-1127
83. Schuijf J.D., Shaw L.J., Wijns W., et al. Cardiac imaging in coronary artery disease: differing modalities. Heart 91 (2005) 1110-1117
84. Bodi V., Sanchis J., Lopez-Lereu M.P., et al. Prognostic value of dipyridamole stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease. J Am Coll Cardiol 50 (2007) 1174-1179
85. Allman K.C., Shaw L.J., Hachamovitch R., and Udelson J.E. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 39 (2002) 1151-1158
86. Bello D., Shah D.J., and Farah G.M. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation 108 (2003) 1945-1953
87. Seghatol F.F., Shah D.J., Deluzio S., et al. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 93 (2004) 854-859
88. Bonow R.O. Identification of viable myocardium. Circulation 94 (1996) 2674-2680
89. Al-Mohammad A., Mahy I.R., Norton M.Y., et al. Prevalence of hibernating myocardium in patients with severely impaired ischaemic left ventricles. Heart 80 (1998) 559-564
90. Carluccio E., Biagioli P., Alumni G., et al. Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization. J Am Coll Cardiol 47 (2006) 969-977
91. Schinkel A.F., Bax J.J., Poldermans D., et al. Hibernating myocardium: diagnosis and patient outcomes. Curr Prob Cardiol 32 (2007) 375-410
92. Camici P.G., Prasad S.K., and Rimoldi O.E. Stunning, hibernation, and assessment of myocardial viability. Circulation 117 (2008) 103-114
93. Kim R.J., Wu E., Rafael A., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343 (2000) 1445-1453
94. Soriano C.J., Ridocci F., Estornell J., et al. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology using late gadolinium-enhanced cardiovascular magnetic resonance. J Am Coll Cardiol 45 (2005) 743-748
95. Al-Khadra A.S., Salem F.D.N., Rand W.M., et al. Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial. J Am Coll Cardiol 31 (1998) 419-425
96. Cotter G., Metzkor E., Kaluski E., et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 351 (1998) 389-393
97. Abraham W.T., Adams K.F., Fonarow G.C., et al. In-hospital mortality in patients with acute compensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure Registry (ADHERE). J Am Coll Cardiol 46 (2005) 57-64
98. The VMAC Investigators. Intravenous nesiritide vs. nitroglycerin for treatment of decompensated congestive heart failure. JAMA 287 (2002) 1531-1540
99. Sackner-Bernstein J.D., Skopicki H.A., and Aaronson K.D. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 111 (2005) 1487-1491
100. Elkayam U., Tasissa G., Binanay C., et al. Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure. Am Heart J 153 (2007) 98-104
101. Gattis W.A., O'Connor C.M., Gallup D.S., Hasselblad V., Gheorghiade M., and IMPACT-HF Investigators and Coordinators. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure. J Am Coll Cardiol 43 (2004) 1534-1541
102. Fonarow G.C., Abraham W.T., Albert N.M., et al., OPTIMIZE-HF Investigators and Coordinators. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival. Am Heart J 153 (2007) 82 e1-11
103. Butler J., Arbogast P.G., Daugherty J., Jain M.K., Ray W.A., and Griffin M.R. Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge. J Am Coll Cardiol 43 (2004) 2036-2043
104. Fonarow G.C., Abraham W.T., Albert N.M., et al., OPTIMIZE-HF Investigators and Coordinators. Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure. J Am Coll Cardiol 52 (2008) 190-199
105. Pitt B., Remme W., Zannad F., et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348 (2003) 1309-1321
106. Gheorghiade M., Abraham W.T., Albert N.M., et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J 28 (2007) 980-988
107. Tsuyuki R.T., Shrive F.M., Galbraith D., et al. Revascularization in patients with heart failure. Can Medical Assn J 175 (2006) 361-373
108. Fonarow G.C., Abraham W.T., Albert N.M., et al. Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design. Am Heart J 148 (2004) 43-51
109. Rott D., Behar S., Leor J., et al. Effect on survival of acute myocardial infarction in Killip classes II or III patients undergoing invasive coronary procedures. Am J Cardiol 88 (2001) 618-623
110. Applegate R.J., Sacrinty M.T., Kutcher M.A., et al. Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007. J Am Coll Cardiol Intv 1 (2008) 317-326
111. McCullough P.A., Adam A., Becker C.R., et al., CIN Consensus Working Panel. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 98S (2006) 5K-13